NPI registry status
Active
2026 NPPES data Neuro-ophthalmology Physician NPI 1285674820 M.D.
Verify on CMS → Bryan Vekovius, M.D.
Neuro-ophthalmology Physician in Shreveport, Louisiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 139 in Neuro-ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
5K
Medicare Part D claims · 1K beneficiaries · Neuro-ophthalmology Physician avg: 487
Industry payments
$11.0K
143 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Bryan Vekovius, M.D. filed 4,786 Medicare Part D claims in 2024 as a Neuro-ophthalmology Physician in Shreveport, Louisiana.
- 5K
- Part D claims, 2024
- $11.0K
- industry payments (Sunshine Act)
- ≥93rd
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Bryan Vekovius, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1285674820), first enumerated 06/08/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 4,786 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$11.0K in reported industry payments (143 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1285674820 · Neuro-ophthalmology Physician
NPI-10 · ENUM-LEGACY · TAX-TRACE · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1285674820
- ENUM-LEGACY 2006
- TAX-TRACE 139
- RX-MID 4,786
- BOOK-THIN 2 in Louisiana
- PHOTO-ENUM Stephen Solomon, DO · 2006
Bryan Vekovius, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
4,786 ≥ 93rd percentile 93% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Bryan Vekovius, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Bryan Vekovius, M.D.?
Quality data not reportedPrimary specialty
Neuro-ophthalmology Physician
Medicare Part D claims
4,786 10× vs specialty avg
Specialty distribution in Louisiana
How Neuro-ophthalmology Physician compares to other specialties among Louisiana providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Neuro-ophthalmology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1285674820 |
|---|---|
| Specialty | Neuro-ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/08/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Bryan Vekovius, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$11.0K
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
4,786
Total Claims
$5.1M
Total Drug Cost
1,141
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 6,162.133
- Total Day Supply
- 140,027
- Generic Drug Cost
- $62K
- Opioid Claims
- 354 (7.4% rate)
- Antibiotic Claims
- 141
Patient Demographics
- Average Patient Age
- 73.4 years
- Avg HCC Risk Score
- 1.23
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 122, 65-74: 464, 75-84: 439, 85+: 116
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Bryan Vekovius, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Erythromycin
Erythromycin
1,242 claims
- Latanoprost
Latanoprost
757 claims
- Ondansetron Hcl 377
Ondansetron Hcl
377 claims
- Hydrocodone-Acetam… 313
Hydrocodone-Acetaminophen
313 claims
- Restasis 183
Restasis
183 claims
- Pyridostigmine Bro… 143
Pyridostigmine Bromide
143 claims
- Dorzolamide-Timolol 130
Dorzolamide-Timolol
130 claims
- Acetazolamide Er 101
Acetazolamide Er
101 claims
| Drug | Claims |
|---|---|
| Erythromycin Erythromycin Base | 1,242 |
| Latanoprost | 757 |
| Ondansetron Hcl | 377 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 313 |
| Restasis Cyclosporine | 183 |
| Pyridostigmine Bromide | 143 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 130 |
| Acetazolamide Er Acetazolamide | 101 |
| Mycophenolate Mofetil | 90 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 88 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neuro-ophthalmology Physician Overview
How Bryan Vekovius, M.D. fits within the Neuro-ophthalmology Physician landscape nationally.
139
Neuro-ophthalmology Physician Providers in US
33
States with Neuro-ophthalmology Physician
487
Avg Claims per Provider
Bryan Vekovius, M.D.'s 4,786 claims are above the specialty average of 487.
Nationwide Neuro-ophthalmology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Vekovius, both outside Louisiana so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Neuro-ophthalmology Physician Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as Vekovius.
Compare Neuro-ophthalmology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Bryan Vekovius, M.D.'s specialty? ▼
Bryan Vekovius, M.D. specializes in Neuro-ophthalmology Physician and practices in Shreveport, Louisiana. Credentials: M.D..
How much does Bryan Vekovius, M.D. prescribe under Medicare Part D? ▼
In 2024, Bryan Vekovius, M.D. wrote 4,786 Medicare Part D claims totaling $5.1M in drug costs for 1,141 beneficiaries.
Where is Bryan Vekovius, M.D. located? ▼
Bryan Vekovius, M.D. is located at 450 ASHLEY RIDGE BLVD, Shreveport, LA, 71106. Phone: (318) 375-3733.
What is Bryan Vekovius, M.D.'s NPI number? ▼
Bryan Vekovius, M.D.'s National Provider Identifier (NPI) is 1285674820, issued on 06/08/2006.
Does Bryan Vekovius, M.D. prescribe opioids? ▼
Yes, Bryan Vekovius, M.D. had 354 opioid claims in 2024 with an opioid prescribing rate of 7.4%.
How many Neuro-ophthalmology Physician providers are there in the US? ▼
There are 139 Neuro-ophthalmology Physician providers across 33 states in the US. The average Neuro-ophthalmology Physician provider writes 487 Medicare Part D claims per year.
What drugs does Bryan Vekovius, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Bryan Vekovius, M.D.'s most frequently prescribed drugs include Erythromycin, Latanoprost, Ondansetron Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Bryan Vekovius, M.D. accept Medicare? ▼
Bryan Vekovius, M.D. appears in CMS Medicare data with 4,786 Part D claims and 1,141 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Bryan Vekovius, M.D.'s credentials? ▼
Bryan Vekovius, M.D.'s NPI is 1285674820 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.